
Company valuation, historical trends, and peer comparisons.
According to Bioventus Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 995.42M. This represents a change of 9.10% compared to the average of 912.35M of the last 4 quarters.
The mean historical Enterprise Value of Bioventus Inc. over the last ten years is 601.42M. The current 995.42M Enterprise Value has changed 65.51% with respect to the historical average. Over the past ten years (40 quarters), BVS's Enterprise Value was at its highest in in the March 2016 quarter at 1.25B. The Enterprise Value was at its lowest in in the March 2015 quarter at 0.
Average
601.42M
Median
721.91M
Minimum
0
Maximum
1.24B
Discovering the peaks and valleys of Bioventus Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 1.24B
Minimum Annual Increase = 0%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 755.78M | -22.90% |
| 2024 | 980.27M | 42.47% |
| 2023 | 688.03M | 25.53% |
| 2022 | 548.11M | -43.65% |
| 2021 | 972.65M | 17.80% |
| 2020 | 825.70M | Infinity% |
| 2019 | 0 | -100.00% |
| 2018 | 1.24B | Infinity% |
| 2017 | 0 | 0% |
| 2016 | 0 | -100.00% |
The current Enterprise Value of Bioventus Inc. (BVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
808.03M
5-year avg
788.97M
10-year avg
601.42M
Bioventus Inc.’s Enterprise Value is greater than Orthofix Medical Inc. (523.71M), greater than Xtant Medical Holdings, Inc. (57.67M), less than Integra LifeSciences Holdings Corporation (2.90B), greater than Organogenesis Holdings Inc. (132.80M), less than Smith & Nephew plc (16.48B), greater than MiMedx Group, Inc. (346.17M), greater than Anika Therapeutics, Inc. (257.92M), greater than TELA Bio, Inc. (64.01M), greater than Bone Biologics Corporation (-4911743.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 523.71M | $392.90M | |
| 57.67M | $41.53M | |
| 2.90B | $1.15B | |
| 132.80M | $111.95M | |
| 16.48B | $13.59B | |
| 346.17M | $466.96M | |
| 257.92M | $273.01M | |
| 64.01M | $37.82M | |
| -4911743.00 | $1.18M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioventus Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bioventus Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Bioventus Inc.'s Enterprise Value?
What is the highest Enterprise Value for Bioventus Inc. (BVS)?
What is the 3-year average Enterprise Value for Bioventus Inc. (BVS)?
What is the 5-year average Enterprise Value for Bioventus Inc. (BVS)?
How does the current Enterprise Value for Bioventus Inc. (BVS) compare to its historical average?